DrugBiological
META10 clinical trials
- studies test it
- 3
- open now
- 3
- in phase 3
- 0
- first study started
- 2025
Keep track of what changes. Save the META10 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
3 studies that test it; most in 2026 (2)
| Year | Studies |
|---|---|
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 1
- Phase 2
- 1
Who runs them
Industry 0 · Other 3
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (2) · Anhui Provincial Hospital (1)
Often tested with
Tested in the same studies.
Izalontamab brengitecan (1) · CVL006 (1) · KXV01 (1) · MT027 (1) · QH101 (1) · TAEST1901 (1) · TCN 201 (1) · Base Edited Natural Killer Cells NK510 (1)
Studies
Open first, then newest update. How each study uses META10 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid TumorsRecruitingEarly Phase 1Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT07349160Written as Metabolically Armed TIL cells.
- Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)Not yet recruitingPhase 1/2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT07307053Written as Meta10-TIL
- Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid TumorsRecruitingEarly Phase 1Anhui Provincial HospitalNCT07106814Written as Metabolically Armed TIL cells